您的位置: 专家智库 > >

国家自然科学基金(30470096)

作品数:15 被引量:26H指数:4
相关作者:陈锦英葛新贺靖冬侯敏张玉梅更多>>
相关机构:天津医科大学天津市疾病预防控制中心天津市第三中心医院更多>>
发文基金:国家自然科学基金国家教育部博士点基金更多>>
相关领域:医药卫生生物学农业科学更多>>

文献类型

  • 15篇中文期刊文章

领域

  • 13篇医药卫生
  • 2篇生物学
  • 2篇农业科学

主题

  • 8篇肾炎
  • 7篇杆菌
  • 6篇致肾盂肾炎大...
  • 6篇肾盂
  • 6篇肾盂肾炎
  • 6篇基因
  • 6篇肠杆菌
  • 5篇细胞
  • 3篇毒力
  • 3篇消减杂交
  • 2篇毒力因子
  • 2篇新基因
  • 2篇抑制性
  • 2篇抑制性消减杂...
  • 2篇杂交
  • 2篇杂交技术
  • 2篇上皮
  • 2篇免疫
  • 2篇聚合酶
  • 2篇基因组

机构

  • 12篇天津医科大学
  • 3篇天津市疾病预...
  • 2篇天津市第三中...
  • 2篇天津市胸科医...
  • 1篇福建医科大学
  • 1篇武警医学院

作者

  • 12篇陈锦英
  • 7篇葛新
  • 4篇侯敏
  • 4篇贺靖冬
  • 3篇张玉梅
  • 3篇谷超
  • 3篇姚萍
  • 2篇赵凤玲
  • 2篇董杰
  • 2篇高英堂
  • 2篇杨东靖
  • 1篇刘晨梅
  • 1篇张维
  • 1篇张连祥
  • 1篇畅继武
  • 1篇郭丽茹
  • 1篇林旭
  • 1篇宋立学
  • 1篇李力
  • 1篇田永琴

传媒

  • 7篇中华微生物学...
  • 2篇天津医科大学...
  • 2篇Scienc...
  • 1篇科学通报
  • 1篇天津医药
  • 1篇中国慢性病预...
  • 1篇Journa...

年份

  • 2篇2011
  • 1篇2010
  • 3篇2009
  • 4篇2008
  • 3篇2007
  • 2篇2006
15 条 记 录,以下是 1-10
排序方式:
致肾盂肾炎大肠埃希菌对细胞的粘附及侵袭
2007年
目的:研究致肾盂肾炎大肠埃希菌(UPEC)132对细胞的粘附和侵袭能力。方法:对比致病菌株UPEC132及无菌毛代表菌株E.coli K-12 p678-54对Vero、Ketr-3及EJ细胞的粘附率、粘附指数和侵袭指数。结果:E.coli K-12p678-54对此3种细胞无粘附无侵袭,而UPEC132对其有明显作用,可致细胞形态明显改变直至死亡。UPEC132对Vero、Ketr-3及EJ细胞的粘附率分别为(61.44±3.21)%、(55.22±4.09)%和(58.67±5.12)%,差别无统计学意义;对3种细胞的粘附指数分别为1.44±0.06、1.74±0.09和2.27±0.18,有显著性差异(P<0.05)。UPEC132对EJ和Ketr-3细胞的侵袭指数分别为(3.25±0.20)×10-3和(3.00±0.34)×10-3,两者之间无统计学差异,但均高于对Vero细胞的侵袭指数[(2.61±0.32)×10-3,P<0.05]。结论:UPEC132对Vero、Ketr-3、EJ细胞均有粘附和侵袭能力,其中对EJ细胞的粘附能力最强,侵袭力也较Vero细胞强,可利用该细胞深入研究UPEC132的毒力及致病机制。
姚萍陈锦英葛新田永琴李力
关键词:粘附
致肾盂肾炎大肠杆菌毒力因子的分布及其与耐药性的关系被引量:5
2008年
目的:探讨致肾盂肾炎大肠杆菌毒力因子的分布及其与耐药性的关系。方法:用PCR和多重PCR方法检测81株尿源大肠杆菌的毒力因子基因papC、fimH、hly、cnf1和aer等;用K-B法进行15种抗菌药物的敏感试验。结果:papC阳性41株(50.6%),为致肾盂肾炎大肠杆菌(UPEC)组,papC阴性40株(49.4%),为非UPEC组。UPEC组hly、aer、fimH、cnf1的检出率依次为63.4%、61.0%、53.7%和34.2%;非UPEC组依次为10.0%、35.0%、12.5%和5.0%;2组之间4种毒力因子的检出率差异均有统计学意义(χ2分别为24.746、7.977、10.281和9.085,P<0.05或P<0.01)。总耐药率为87.65%,UPEC组和非UPEC组的多重耐药率之间差异有统计学意义(P<0.01),前者(87.8%)明显高于后者(50%)。结论:UPEC菌株毒力因子检出率高,多重耐药性突出,应引起临床上的高度重视。
侯敏贺靖冬陈锦英张连祥刘晨梅
关键词:肾盂肾炎大肠杆菌聚合酶链反应微生物敏感性试验
Comparison of infection of different cell lines by uropathogenic Escherichia coli被引量:3
2009年
Studying the interaction between uropathogenic Escherichia coli (UPEC) and uroepithelial cells is important in elucidating the pathogenesis of urinary tract infection. In this study, the African green monkey kidney cells (Vero), human kidney carcinoma cells (Ketr-3) and bladder carcinoma cells (EJ) were infected by UPEC132, a clinical strain isolated from Tianjin, China, and were compared for their capacities to allow the adherence and invasion by this strain. The results revealed that all these cell lines could be attached and invaded by UPEC132. The adherence rates for Vero, Ketr-3 and EJ cells were (49.20 ± 7.55)%, (55.22 ± 4.09)% and (73.20 ± 5.26)%, respectively, and invasion frequencies were (2.61 ± 0.32)×10-3, (3.00 ± 0.34)×10-3 and (3.25 ± 0.20)×10-3, respectively. The statistical analysis showed that the adherence rate for EJ cells was significantly higher than those for the other two cell lines (P<0.05), and the invasion frequencies for EJ and Ketr-3 cells had no statistical differences (P>0.05) but were higher than that for Vero cells (P<0.05). Three cell lines were detected for the receptors for P pili of UPEC by using indirect immunofluorescence. The results showed that receptors existed on the surfaces of all cell lines, and the highest distribution was found on the surface of EJ cells. Additionally, the invasion of EJ cells by recombinant UPEC132/pSELECT-GFP could be directly visualized using confocal microscopy. These data strongly implicated that EJ cells could be more easily infected by UPEC132 than the other cells, and thus could serve as a good experimental target for further investigation of UPEC infection.
GE Xin DONG Jie CHEN JinYing YAO Ping GU Chao YANG DongJing
关键词:大肠杆菌感染细胞株肾炎
致肾盂肾炎大肠埃希菌新基因R049免疫保护作用的研究被引量:4
2008年
目的克隆和表达致肾盂肾炎大肠埃希菌(UPEC)132新基因R049,研究R049重组蛋白对小鼠的免疫保护作用。方法利用PCR定向克隆方法构建R049基因原核表达系统,表达后通过镍亲和层析纯化获得R049重组蛋白,制备鼠多克隆抗体。重组蛋白与UPEC132全菌蛋白经SDS-PAGE和Western blot分析,继而R049重组蛋白免疫BALB/c小鼠,用同源菌对小鼠经尿道上行感染,比较免疫组与对照组小鼠尿液与肾脏细菌计数差异。结果成功构建重组株E.coli BL21(DE3)/pET32a-R049ORF,重组蛋白相对分子质量(MT)约为66.9×10^3,纯化后其纯度达到95%,制备多克隆抗体效价为≥1:102400。Western blot证实重组R049蛋白与UPEC132全菌蛋白均能与小鼠抗血清发生特异性反应。动物实验结果表明尿液和肾脏菌落计数在免疫组均明显低于对照组(P〈0.01,P〈0.05)。结论UPEC132的新基因R049具有一定的免疫保护作用,其机制有待进一步研究。
葛新张玉梅陈锦英林旭赵凤玲
关键词:克隆表达免疫保护动物实验
Adherence of uropathogenic Escherichia coli to human primary epithelial cells of renal pelvis
2006年
Human primary epithelial cells of renal pelvis was established to investigate the adherence of uropathogenic Escherichia coli (UPEC) to this cell line, in which the primary cell culture was performed by using cultivation of the normal epithelium of renal pelvis in keratinocyte serum free medium (K-SFM) with epidermal growth factor (EGF) and bovine pituitary extract (BPE). Both UPEC132 obtained from urine specimen of patients with pyelonephritis and the pilus-free representative strain E. coli K-12p678- 54 were used to study the adherence of these strains on human primary epithelial cells of renal pelvis. The UPEC adherence was performed with observation on the morphological changes of the adhered cells, while the adhesion rates and indices were calculated in different times of experiment. In addition, the virulence genes hly and cnfl of UPEC132 were detected by multiplex PCR assay. In this study, the human primary epithelial cells of renal pelvis was found to exhibit the character of the transitional epithelial cells. Compared with the control group, the adhesion rates and indices began to increase from 15 min of the experiment time and reached its peak in 120 min. The adhesion rate and index of UPEC132 to human primary epithelial cells of renal pelvis were 74.4% and 34.0 respectively. Many microscopic changes in the primary cells adhered with UPEC132 could be detected, such as rounding or irregularity in shape, unevenness in staining and the cytoplasmic and nuclear changes. It suggests that human primary epithelial cells of renal pelvis can be used for the experiment on UPEC adhesion, thus providing a basis for the further study on the pathogenesis of UPEC.
CHAO GUJIN YING CHENMIN HOUJING DONG HEJI WU CHANG
A novel gene R049 identified in uropathogenic Escherichia coli provides partial protection in mice from colonization
2011年
Uropathogenic Escherichia coli(UPEC) is the most common causative organism of human urinary tract infection(UTI).Several UPEC virulence factors have been identified,but more are yet to be found.We previously identified a novel 789-bp-long DNA fragment(named R049) in UPEC strain 132 using a suppressive subtractive hybridization technique.In the present study,we used genome walking to elongate the sequence of this fragment to obtain the whole gene sequence and examined the role of this gene product in generating protective immunity.Through bioinformatic analysis,we predicted that this gene is a 1311-bp open reading frame(ORF),which we designated ORFR049(GenBank accession No.:EF488001).We further constructed a prokaryotic expression system to express full recombinant R049 protein and isolated and purified the protein through IPTG induction and nickel affinity chromatography.Using mouse immunosera generated by the purified protein,we confirmed the natural expression and outer membrane localization of the protein in wild-type strain UPEC132 by Western blotting.To test the potential of this protein as a vaccine candidate,we immunized mice with the recombinant protein before challenging them with UPEC132 through the urinary tract.The results showed significantly reduced bacterial colonization in the urine and kidneys of the immunization group compared with the control group.However,the degree of renal pathological damage was not significantly improved in the immunized mice.Our study has identified a novel gene of UPEC which can generate protective immunity against UTI.This novel gene provides a promising new vaccine candidate.
CHEN JinYingGE XinZHANG YuMeiLIN XuZHANG WeiYANG Xi
关键词:保护性免疫免疫小鼠肾炎抑制消减杂交技术GENBANK
致肾盂肾炎大肠埃希菌132基因组DNA消减文库的构建
2006年
目的:应用抑制性消减杂交技术,构建致肾盂肾炎大肠埃希菌132株(UPEC132)与已完成基因组测序的非致病性大肠埃希菌标准株MG1655的基因组DNA消减文库。方法:分别提取UPEC132与MG1655的基因组DNA,经RsaⅠ酶切成为大小200~800bp的片段,一部分与接头连接作为tester,和未与接头连接的酶切片段(driver)进行2次消减杂交及2次抑制性PCR后将产物与pMD18-T载体连接构建DNA消减文库,并转化给大肠埃希菌TOP10构建消减文库。结果:文库扩增后得到139个克隆,经PCR法快速测定,均得到200~800bp的插入片段。结论:所构建的基因组DNA消减文库为进一步筛选UPEC132中与致病相关基因奠定了基础。
宋立学陈锦英
关键词:抑制性消减杂交聚合酶链式反应基因组消减文库
致肾盂肾炎大肠杆菌132的比较蛋白质组学研究
2008年
目的研究致肾盂。肾炎大肠杆菌(UPEC)132与UPEC J96及非致病性大肠杆菌K-12MG1655的蛋白质组表达差异。方法采用双向凝胶电泳技术(2-DE)比较UPEC 132、UPEC J96与非致病性大肠杆菌K-12MG1655的菌体蛋白表达图谱差异,差异蛋白用胰蛋白酶进行胶内酶切,肽混合物使用基质辅助激光解吸-电离飞行时间质谱仪(MALDI—TOF—MS)进行质谱分析,将肽质量指纹谱数据输入互联网上的蛋白质数据库进行检索。结果UPEC132识别蛋白点数(466±11)明显高于Ecoli K-12 MG1655(338±15),也高于UPEC J96(382±12);3菌株共有的蛋白点为298个,2株UPEC共有的蛋白点为56个,UPEC 132特有的蛋白点为89个。MALDI—TOF—MS分析获得UPEC132特异的及显著上调表达的蛋白点22个,涉及毒力因子、物质代谢转运、蛋白合成调节、生物氧化及未知功能的多种蛋白质。结论UPEC菌株与非致病性大肠杆菌间的蛋白质组存在差异,UPEC 132与J96蛋白质组间也有显著不同,为其致病机制的深入研究提供线索。
郭丽茹陈锦英杨东靖董杰
关键词:致肾盂肾炎大肠杆菌比较蛋白质组学生物氧化
致肾盂肾炎大肠杆菌特异性片段R049聚集性分布的研究被引量:5
2008年
目的研究致肾盂肾炎大肠杆菌(UPEC)132特异性片段R049在UPEC菌株和正常人粪便分离的大肠杆菌菌株中的分布情况。方法对20株UPEC和40株粪便分离大肠杆菌采用PCR方法扩增R049片段,对R049阳性菌株检测编码5种毒力因子的基因(papC、fimH、hfy、aer、cnfl),并对其基因组DNA用XbaⅠ酶切,进行脉冲场凝胶电泳分析,继而用毛细管法将DNA片段转移至尼龙膜,利用地高辛标记的R049 ORF探针片段进行Southern杂交,分析杂交条带的分布特征。结果20株UPEC中有8株(40%)、40株粪便分离的大肠杆菌中有3株(7.5%)R049片段扩增阳性,两组差异有统计学意义(P〈0.01)。R049阳性菌株中,R049片段与5种UPEC毒力因子密切相关。Southern杂交结果表明3株粪便分离大肠杆菌R049阳性杂交带分别为150kb、15kb与240kb;8株UPEC中有6株阳性杂交带均为350kb,其余2株分别为280kb和25kb。结论UPEC132特异性片段R049在国内分离的UPEC菌株中具有共有性和聚集性分布的特征。
葛新陈锦英张玉梅高英堂侯敏贺靖冬
关键词:致肾盂肾炎大肠杆菌脉冲场凝胶电泳SOUTHERN杂交
致肾盂肾炎大肠杆菌132特异性基因的筛选被引量:6
2007年
目的 通过抑制性消减杂交(suppression subtractive hybridization,SSH)技术,比较致肾盂肾炎大肠杆菌132(UPEC132)与非致病性E.coliK-12MG1655之间基因组的差异,筛选UPEC132特有的基因片段。方法 应用SSH技术构建UPEC132(tester)与非致病性E.coliK-12MG1655(driver)菌株差异DNA消减文库,经PCR和斑点印迹法筛选鉴定阳性克隆,并进行测序及生物信息学分析。结果获得约1600个重组菌的UPEC132消减文库,随机挑取其中的300个克隆,有37个含有UPEC132特异的DNA序列。特异性片段测序后进行生物信息学分析,发现与其相关的37个基因为UPEC132所特有,其中1个为新发现的DNA片段,9个为与致病相关基因,7个为与代谢和物质转运相关基因,2个为与外膜蛋白相关基因,3个为与调节相关基因,10个为未知功能蛋白的基因,其他5个为功能未分类的基因。结论 SSH技术是筛选病原菌特异基因的有效方法,已确定了37个UPEC132的特异基因,为进一步阐明其致病分子机制打下了基础。
张玉梅陈锦英高英堂刘欣
关键词:致肾盂肾炎大肠杆菌特异基因斑点印迹
共2页<12>
聚类工具0